Clinical trial
Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian…
NCT00170664 · North Eastern German Society of Gynaecological Oncology, Other · Completed
Key facts
| NCT number | NCT00170664 |
|---|---|
| Title | Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer |
| Lead sponsor | North Eastern German Society of Gynaecological Oncology, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Carboplatin |
| Enrollment | 129 |
| Start date | Jan 1, 1999 |
| Primary completion | Mar 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 25, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: